9364:TSEKamigumi Co., Ltd. Analysis
Data as of 2026-05-27 - not real-time
¥4,732.00
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Kamigumi Co., Ltd. is trading at ¥4,732, just above its recent support of ¥4,681 and well below the 52‑week high of ¥5,818. The RSI of 26 indicates the stock is oversold, while the MACD histogram remains negative, suggesting short‑term bearish momentum but a potential bounce off support as volume has been increasing.
Fundamentally, the company delivers a solid dividend yield of 4.44% with a payout ratio of 66%, supported by positive operating and free cash flow. Its trailing P/E of 15.2 is far below the industry average of 30.1, yet the DCF‑derived fair value of ¥3,086 implies the current price is significantly overvalued. The balance sheet shows high leverage (debt‑to‑equity 17.7) but ample cash reserves, and revenue is growing modestly at 4.5% annually. Overall, the stock presents an attractive dividend and low relative valuation on a P/E basis, but the discrepancy with intrinsic value and elevated leverage temper enthusiasm.
Fundamentally, the company delivers a solid dividend yield of 4.44% with a payout ratio of 66%, supported by positive operating and free cash flow. Its trailing P/E of 15.2 is far below the industry average of 30.1, yet the DCF‑derived fair value of ¥3,086 implies the current price is significantly overvalued. The balance sheet shows high leverage (debt‑to‑equity 17.7) but ample cash reserves, and revenue is growing modestly at 4.5% annually. Overall, the stock presents an attractive dividend and low relative valuation on a P/E basis, but the discrepancy with intrinsic value and elevated leverage temper enthusiasm.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- RSI indicating oversold conditions
- Price hovering just above recent support
- Increasing trading volume
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Attractive dividend yield with sustainable payout
- P/E well below industry average
- Overvaluation relative to DCF fair value
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- Stable cash flow generation
- High leverage requiring monitoring
- Long‑term dividend income potential
Key Metrics & Analysis
Financial Health
Revenue Growth4.50%
Profit Margin10.61%
P/E Ratio15.2
ROE8.02%
ROA4.44%
Debt/Equity17.74
P/B Ratio1.2
Op. Cash Flow¥35.7B
Free Cash Flow¥17.8B
Industry P/E30.1
Technical Analysis
TrendNeutral
RSI26.2
Support¥4,681.00
Resistance¥5,330.00
MA 20¥5,074.00
MA 50¥5,313.20
MA 200¥5,018.05
MACDBearish
VolumeIncreasing
Fear & Greed Index91.05
Valuation
Fair Value¥3,086.25
Target Price¥5,676.67
Upside/Downside19.96%
GradeOvervalued
TypeBlend
Dividend Yield4.44%
Risk Assessment
Beta-0.02
Volatility20.12%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.